Table 2.
Validity estimates for MacroH2A1.1 and QKI expression levels as diagnostic biomarkers for prostate cancer identification
| Parameter | MacroH2A1.1 performance | DDX5 performance | DDX17 performance | QKI performance |
|---|---|---|---|---|
| Sensitivity (%) | 80.7 | 82.7 | 47.3 | 88.8 |
| Specificity (%) | 93.3 | 93.3 | 93.3 | 93.3 |
| Accuracy (%) | 81.6 | 83.5 | 50.5 | 88.7 |
| Positive likelihood ratio (LR+) | 12.04 | 12.34 | 7.06 | 13.25 |
| Negative likelihood ratio (LR−) | 0.21 | 0.19 | 0.56 | 0.12 |
| AUC (95% IC) p value |
0.92 (0.876–0.965) p < 0.0001 |
0.65 (0.549–0.751) p = 0.0533 |
0.93 (0.872–0.980) p < 0.0001 |
0.94 (0.897–0.987) p < 0.0001 |